Nawal Zeitouni
Pediatrics · Lubbock, TXNPI 1427051572
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 139 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by Supernus Pharmaceuticals, Inc. at 38.6% of the total. Reporting peaked in 2024 at $1,161 and has fallen 56.8% since, to $502 in 2025. Among pediatrics clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 139 payments — averaging $24.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supernus Pharmaceuticals, Inc.$1K
- Corium, LLC$502
- Regeneron Healthcare Solutions, Inc.$280
- GSK$233
- Takeda Pharmaceuticals U.S.A., Inc.$220
- Ironshore Pharmaceuticals Inc.$203
- plus $619 from 14 others
What the payments were for
- Food & beverage$3,348100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 34 | $1,291 |
| Corium, LLC | 24 | $502 |
| Regeneron Healthcare Solutions, Inc. | 14 | $280 |
| GSK | 14 | $233 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $220 |
| Ironshore Pharmaceuticals Inc. | 8 | $203 |
| Novartis | 9 | $151 |
| Sanofi | 4 | $81 |
| Collegium Pharmaceutical, Inc. | 4 | $80 |
| Pfizer | 3 | $55 |
| Genentech USA, Inc. | 3 | $48 |
| Aimmune Therapeutics, Inc. | 2 | $35 |
| Kaleo, Inc. | 2 | $33 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $28 |
| Sanofi Pasteur Inc. | 1 | $27 |
| AstraZeneca | 1 | $21 |
| Merck | 1 | $17 |
| CSL Behring | 1 | $15 |
| Seqirus USA Inc | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QELBREE$673
How this compares
$3,348 in reported general payments places this provider in the 95th percentile of 5,361 pediatrics providers in Texas.
Other pediatrics in Lubbock
- Pedro PiedraHouston$729K
- Jason RiehsFrisco$216K
- Ivonne Sahagun-CarreonNew Braunfels$168K
- Angela ScheuerleDallas$118K
- Dianna BurnsSan Antonio$100K
- Jason TerkKeller$93K
- Vernon SuttonHouston$90K
- Laura ScalfanoPlano$74K
- Patricia AmersonSan Antonio$73K
- Ralph DeberardinisDallas$56K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.